Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 12 studies | 42% ± 18% | |
| microglial cell | 7 studies | 28% ± 12% | |
| GABAergic neuron | 6 studies | 26% ± 10% | |
| endothelial cell of lymphatic vessel | 6 studies | 48% ± 17% | |
| macrophage | 4 studies | 25% ± 8% | |
| neuron | 3 studies | 19% ± 1% | |
| glutamatergic neuron | 3 studies | 28% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 941.54 | 89 / 89 | 89% | 22.10 | 801 / 901 |
| skin | 99% | 307.73 | 1789 / 1809 | 80% | 15.68 | 378 / 472 |
| breast | 100% | 547.08 | 459 / 459 | 59% | 10.87 | 662 / 1118 |
| brain | 94% | 277.12 | 2495 / 2642 | 60% | 8.45 | 420 / 705 |
| uterus | 99% | 364.26 | 169 / 170 | 20% | 2.21 | 90 / 459 |
| lung | 93% | 160.14 | 536 / 578 | 22% | 2.48 | 257 / 1155 |
| pancreas | 80% | 103.92 | 261 / 328 | 35% | 1.93 | 63 / 178 |
| thymus | 99% | 333.79 | 648 / 653 | 10% | 1.37 | 61 / 605 |
| stomach | 100% | 390.80 | 358 / 359 | 8% | 0.37 | 23 / 286 |
| bladder | 100% | 470.19 | 21 / 21 | 5% | 0.57 | 26 / 504 |
| esophagus | 89% | 213.86 | 1290 / 1445 | 16% | 1.08 | 29 / 183 |
| ovary | 76% | 99.98 | 137 / 180 | 27% | 2.60 | 114 / 430 |
| adipose | 100% | 538.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 93% | 201.46 | 898 / 966 | 5% | 0.56 | 27 / 527 |
| blood vessel | 92% | 235.67 | 1229 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 86% | 124.13 | 211 / 245 | 0% | 0.01 | 1 / 502 |
| muscle | 37% | 37.56 | 295 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 17% | 13.76 | 44 / 258 | 12% | 1.29 | 28 / 230 |
| heart | 18% | 21.72 | 159 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 13% | 18.90 | 125 / 929 | 0% | 0 | 0 / 0 |
| spleen | 12% | 11.66 | 30 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.39 | 7 / 80 |
| liver | 0% | 0 | 0 / 226 | 2% | 0.18 | 9 / 406 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0018105 | Biological process | peptidyl-serine phosphorylation |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | STK32B |
| Protein name | Serine/threonine-protein kinase 32B (EC 2.7.11.1) (Yet another novel kinase 2) Serine/threonine kinase 32B |
| Synonyms | UNQ3003/PRO9744 YANK2 |
| Description | |
| Accessions | E9PCC0 D6R9Y2 ENST00000282908.10 [Q9NY57-1] ENST00000510398.1 [Q9NY57-2] Q9NY57 ENST00000512636.5 ENST00000512018.5 |